Syndax Pharmaceuticals SNDX
NASDAQ SNDX
$17.97 -0.25 (-1.37%)
As of: Oct 2, 2026 · 10:20 AM EDT

Syndax Pharmaceuticals (SNDX) Accumulated Expenses (2015 - 2026)

Updated

Syndax Pharmaceuticals' Accumulated Expenses was $94.3 million in Q2 2026, up 32.7% from $71.07 million a year earlier and up 26.0% from the prior quarter.

Analysis

Syndax Pharmaceuticals (SNDX) Accumulated Expenses (2015 - 2026) Analysis & Trends

At the end of FY2025, Accumulated Expenses at Syndax Pharmaceuticals came in at $103.06 million, up 71.5% from FY2024.

  • Accumulated Expenses has now increased for four consecutive years, with a five-year compound annual growth rate of 33.5% (FY2020 to FY2025).
  • In earlier years, Accumulated Expenses was $60.1 million in FY2024 (+50.8%), $39.86 million in FY2023 (+64.2%), $24.28 million in FY2022 (+67.8%) and $14.47 million in FY2021 (-40.4%).
  • Quarterly Accumulated Expenses has moved between $13.21 million (Q3 2022) and $103.06 million (Q4 2025) over five years.
  • Compared with a year earlier, Accumulated Expenses has increased for 13 straight quarters, with growth averaging 66.4% over the last eight quarters.
  • The best year-over-year quarter for Accumulated Expenses over five years was Q2 2025 (growth of 165.1%); the worst was Q4 2021 (a decline of 40.4%).
  • Per Business Quant data, SNDX's Accumulated Expenses in the three quarters before Q2 2026 was $74.84 million (Q1 2026), $103.06 million (Q4 2025) and $77.11 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Syndax Pharmaceuticals 1.68 Bn -53.94 Mn 69.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 94.30 Mn
Mar 31, 2026 74.84 Mn
Dec 31, 2025 103.06 Mn
Sep 30, 2025 77.11 Mn
Jun 30, 2025 71.07 Mn
Mar 31, 2025 55.98 Mn
Dec 31, 2024 60.10 Mn
Sep 30, 2024 48.12 Mn
Jun 30, 2024 26.81 Mn
Mar 31, 2024 33.40 Mn
Dec 31, 2023 39.86 Mn
Sep 30, 2023 32.12 Mn
Jun 30, 2023 17.73 Mn
Mar 31, 2023 15.21 Mn
Dec 31, 2022 24.28 Mn
Sep 30, 2022 13.21 Mn
Jun 30, 2022 16.97 Mn
Mar 31, 2022 18.42 Mn
Dec 31, 2021 14.47 Mn
Sep 30, 2021 13.73 Mn
API Access

Syndax Pharmaceuticals Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEY